Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
EmailIphone Application    Posted: 5th February 2021
If you would like to forward this story on to a friend, simply fill in the form below and click send.
Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Product recall for Otadex Skin Cream
Otadex Skin Cream as the lidocaine content is marginally our of specification.

Lidocaine content is marginally out of specification.

The Veterinary Medicines Directorate (VMD) has issued a product defect recall alert for Otadex Skin Cream manufactured by PetLife International Ltd. 

In a news release, the VMD writes: 'We wish to make retailers and veterinary surgeons aware that Petlife International Ltd has initiated a Class II recall to retail level for the product Otodex Skin Cream as the lidocaine content is marginally out of specification.

'Petlife International Ltd is contacting retailers, veterinary surgeons and wholesale dealers to examine inventory immediately and quarantine products subject to this recall.'

The recall affects batches:

 

Batch No.
 Expiry date
E001 31/03/2021
E002 31/01/2021


For further information about the recall contact  Dr J M Ballany on +44 1333 720257 or email johnballany@btinternet.com

 

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
Lords Committee opens Pet Parasite Medication inquiry

The House of Lords Environment and Climate Change Committee will launch its inquiry into Pet Parasite Medication (PPM) on Wednesday (3 June).

Focusing on treatments containing fipronil and imidacloprid, the inquiry will seek to understand distribution pathways and the impacts of PPM use and non-use on biodiversity and human health. It will also cover current regulation, monitoring, and the potential implications for pets and their owners.

The committee will hear evidence from environmental non-governmental organisations and research institutes. The public can follow the proceedings live on Parliament TV or in person in the Palace of Westminster.